John S. McCain Opioid Addiction Prevention Act
- Last Action
- 4/12/2019
Actions
- 2019-04-12Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
- 2019-03-08Referred to the Subcommittee on Health.
- 2019-03-07Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2019-03-07Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2019-03-07Introduced in House
- 2019-03-07Introduced in House
CRS Summary
As of 2019-03-07 (00)
John S. McCain Opioid Addiction Prevention Act
This bill establishes a new registration requirement for practitioners who are licensed to prescribe controlled substances in schedule II, III, or IV.
Specifically, a practitioner must agree to limit the supply of opioids prescribed for the initial treatment of acute pain, as a condition of obtaining or renewing a registration through the Drug Enforcement Administration.
An opioid that is approved and prescribed for the treatment of addiction is not subject to the limit.
Cosponsors (7)
- Thomas Suozzi (D-NY)
- Dean Phillips (D-MN)
- Chris Collins (R-NY)
- Susie Lee (D-NV)
- Carol Miller (R-WV)
- Susan Brooks (R-IN)
- Guy Reschenthaler (R-PA)
Subjects
- Drug therapy
- Drug trafficking and controlled substances
- Drug, alcohol, tobacco use
- Health personnel
- Licensing and registrations
- Prescription drugs
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.